Novel Microbial Insecticide Product Makes Short List for Two Major Innovation Awards

FOR IMMEDIATE RELEASE

LIBERTYVILLE, IL., October 9, 2009 – A biological insecticide introduced this year by Valent BioSciences Corporation is a finalist in two programs designed to recognize innovative new products.

VectoMax® Biological Larvicide, used by public health agencies to control nuisance and disease carrying mosquitoes, has earned accolades in competitions in Chicago and the United Kingdom.

The product is a finalist for the Innovation in Non-Crop category award to be presented in November by London-based Agrow, a leading information provider for the global crop protection industry. The award is aimed outside the traditional crop protection arena to the expanding non-food crop sector. Among other finalists in the category are Dow AgroSciences and DuPont Professional Products.

VectoMax Biological Larvicide also is a finalist in the Chicago Innovation Award program. The Chicago Innovation Awards bring attention to the locally developed product and service innovations that are making an impact on the world. Awards will be presented October 20.

About the Product
VectoMax Biological Larvicide contains two naturally occurring bacteria -Bacillus thuringiensis israelensis (Bti), and Bacillus sphaericus (Bs). Each is long known to control all mosquito pest species.

The key to providing broad spectrum, long-lasting mosquito control lies within company’s proprietary BioFuseTM Technology that combines the Bti and Bs protoxins into single particles during the manufacturing process. VectoMax Biological Larvicide works when it is applied to bodies of water that contain mosquito larvae. VectoMax Biological Larvicide is ingested by the hungry larvae, quickly activated in the larval gut, and causes mortality within 24 hours.

The Bti and Bs bacteria particle does not adversely affect populations of other organisms including fish, plants or humans. By combining the two bacteria into a single food particle for mosquito larvae, control program managers can reduce the expense associated with multiple applications of pesticides. By killing the larvae, VectoMax Biological Larvicide prevents them from developing into free-flying adult mosquitoes, which are capable of transmitting disease or causing a biting nuisance.

About Valent BioSciences Corporation
About Valent BioSciences Corporation: Headquartered in Libertyville, IL, Valent BioSciences is a subsidiary of Tokyo-based Sumitomo Chemical Company. Valent BioSciences is the worldwide leader in the development, manufacturing and commercialization of biorational products, with sales in 95 countries around the world. Valent BioSciences is an ISO 9001:2008 Certified Company. For additional information, visit the company’s website at www.valentbiosciences.com.

Media Contact:
Barbara Wendling
Valent BioSciences Corporation
847-968-4793
Email: barbara.wendling@valentbiosciences.com

Download Press Release

Share:

Related News

Valent BioSciences LLC, the global biorational products leader in agriculture, public health, and forest health, has announced that the company began selling biostimulant products directly to its U.S. customer base on October 1.
Sumitomo Chemical Co., Ltd. (SCC), parent company of Valent U.S.A. and Valent Biosciences, today announced a new entity called Valent North America that will provide enterprise business services across the Valent group of companies. 
Valent BioSciences LLC, the global biorational products leader in agriculture, public health, and forestry, has announced the promotion of Salman Mir to Executive Vice President and Chief Operating Officer. He will continue reporting to Ted Melnik, Valent BioSciences’ President and Chief Executive Officer.
To promote its industry leadership in biorational and biostimulant product innovation, Valent BioSciences LLC has announced significant investments at several of its key research and development facilities.
Valent BioSciences LLC announced today that it has approved a major expansion of its biorational manufacturing facility in Osage, Iowa, which will meet increasing demand for its biorational products and the introduction of new products requiring more capacity.
The U.S. Environmental Protection Agency recently granted Valent BioSciences LLC an Experimental Use Permit (EUP) to perform further field studies of VBC-60748, a new mosquito space spray targeting pyrethroid-resistant adult mosquitoes.